On Feb 17, 2026, MED reported earnings of -1.65 USD per share (EPS) for Q4 25, missing the estimate of -0.82 USD, resulting in a -99.23% surprise. Revenue reached 75.10 million, compared to an expected 74.54 million, with a 0.75% difference. The market reacted with a -0.83% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 2 analysts forecast an EPS of -0.52 USD, with revenue projected to reach 69.89 million USD, implying an decrease of -68.48% EPS, and decrease of -6.93% in Revenue from the last quarter.